Thermo Fisher Scientific plans to invest $35 million in a pharmaceutical services supply-chain facility in Rheinfelden (Baden) Germany.

The new facility will increase capacity for cold and ambient clinical trial materials in support of clinical research. The facility will be scalable for mixed-use space and provide a logistical location for shipping either by road or air.

The company expects to start construction in the fourth quarter of 2018 for the 8,000-square-meter facility at the 26,000-square-meter site with an anticipated completion within 12 to 18 months. Once complete, the new facility is expected to provide up to 200 new jobs locally. The investment includes the option for additional expansion with the potential for doubling the footprint.

This facility builds on the company’s existing footprint of 20 cGMP facilities globally.                         

Source: Thermo Fisher Scientific